Stay updated on CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial

Sign up to get notified when there's something new on the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-11-02T15:51:12.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces transition updates and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.
    Difference
    1%
    Check dated 2026-10-26T15:58:55.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page continues to show a 403 Forbidden error, with the displayed site revision changing from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T20:51:49.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision label advanced from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T03:57:22.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the typical study record content with an access message. Core elements such as sponsor details, eligibility criteria, locations, and outcomes are no longer visible due to the error.
    Difference
    18%
    Check dated 2026-09-21T22:53:57.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision: v3.6.6 replaces v3.6.5 as the page's version marker, indicating a small update to the site's code or content management. No changes to the study details, eligibility criteria, or results are introduced.
    Difference
    0.1%
    Check dated 2026-08-31T17:30:16.000Z thumbnail image

Stay in the know with updates to CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page.